IκB-γ Activators
IκB-γ Activators are a diverse group of chemical compounds that enhance the functional activity of IκB-γ by modulating signaling pathways or cellular processes that IκB-γ is directly involved in. Anisomycin, by stimulating the SAPK/JNK pathway, indirectly contributes to IκB-γ activation due to its role in the phosphorylation and degradation of IκB proteins, enhancing NF-κB activity. Bay 11-7082 and MG-132 both act to increase IκB-γ levels, the former by blocking phosphorylation of a related IκB protein (IκBα) and the latter by inhibiting the proteasome, preventing the degradation of IκB proteins. Pervanadate activates Src family kinases, indirectly affecting NF-κB activity, while PS-1145, TPCA-1, and BMS-345541, all IKK inhibitors, paradoxically lead to the accumulation of IκB proteins like IκB-γ, enhancing NF-κB nuclear translocation regulation.
Sulfasalazine and Curcumin both inhibit NF-κB activation but may positively influence IκB-γ by modulating the NF-κB signaling pathway and stabilizing the NF-κB/IκB complex, thereby enhancing the role of IκB-γ in the regulation of NF-κB. The natural compound Parthenolide and the synthetic molecule Andrographolide also inhibit NF-κB activation but stabilize IκB proteins, including IκB-γ, leading to increased regulatory control over NF-κB activity. Finally, the reducing agent Dithiothreitol (DTT) indirectly maintains the structure and function of IκB-γ under oxidative conditions, which can influence its regulatory role. Collectively, these IκB-γ Activators, through their targeted effects on cellular signaling and protein stability, orchestrate the enhancement of IκB-γ's function in NF-κB pathway regulation without directly increasing its expression or requiring its direct activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin acts as a JNK activator by interfering with protein synthesis and inducing stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling. This kinase cascade is linked to the regulation of IκB proteins, and the activation of JNK can lead to the phosphorylation and subsequent degradation of IκB proteins such as IκB-γ, thereby enhancing the activity of NF-κB. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Bay 11-7082 is an inhibitor of IκBα phosphorylation. By selectively blocking IκBα phosphorylation, it indirectly increases the nuclear translocation and activity of NF-κB, which can include the IκB-γ-mediated regulation of NF-κB's nuclear activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a proteasome inhibitor that prevents the degradation of ubiquitinated proteins. By inhibiting the proteasome, MG-132 can increase the levels of IκB proteins, including IκB-γ, thus enhancing NF-κB activity through the stabilization of its inhibitory complex. | ||||||
Stat5 Inhibitor | 285986-31-4 | sc-355979 sc-355979A | 10 mg 100 mg | $208.00 $1532.00 | 36 | |
PS-1145 is an inhibitor of IKK, which phosphorylates IκB proteins leading to their degradation. By inhibiting IKK, PS-1145 can paradoxically lead to the accumulation of IκB proteins, including IκB-γ, and thereby modulate NF-κB activity in cells. | ||||||
IKK-2 Inhibitor IV | 507475-17-4 | sc-203083 | 500 µg | $133.00 | 12 | |
TPCA-1 is an inhibitor of IKK-2, a kinase involved in the phosphorylation and degradation of IκB proteins. Its inhibition can result in increased levels of IκB proteins, including IκB-γ, thus influencing the functional activity of NF-κB. | ||||||
BMS-345541 | 445430-58-0 | sc-221741 | 1 mg | $312.00 | 1 | |
BMS-345541 selectively inhibits IKK, preventing the phosphorylation and degradation of IκB proteins. This results in increased levels of IκB proteins like IκB-γ, which can enhance NF-κB activity by regulating its nuclear translocation. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
Sulfasalazine is known to inhibit NF-κB activation by blocking the nuclear translocation of the p65 subunit. It can also influence IκB-γ function by modulating NF-κB signaling pathways, thus affecting the overall activity of the NF-κB complex. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is a natural compound that can inhibit NF-κB activation by suppressing IKK activity, leading to an accumulation of IκB proteins including IκB-γ. This accumulation indirectly enhances NF-κB activity by stabilizing the NF-κB/IκB complex. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Parthenolide inhibits NF-κB activation by preventing IκBα degradation. It can also affect IκB-γ by stabilizing the NF-κB/IκB complex, leading to enhanced NF-κB activity through indirect mechanisms. | ||||||
Andrographolide | 5508-58-7 | sc-205594 sc-205594A | 50 mg 100 mg | $15.00 $40.00 | 7 | |
Andrographolide can inhibit NF-κB activation by covalently modifying cysteine residues on IKK, leading to the stabilization of IκB proteins, including IκB-γ. This enhances the regulatory role of IκB-γ on NF-κB signaling. | ||||||